Mechanisms of Naringenin-induced Apoptotic Cascade in Cancer Cells: Involvement of Estrogen Receptor a and ß Signalling
✍ Scribed by Pierangela Totta; Filippo Acconcia; Stefano Leone; Irene Cardillo; Maria Marino
- Book ID
- 111741540
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 794 KB
- Volume
- 56
- Category
- Article
- ISSN
- 1521-6543
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Adipositas correlates with an enhanced risk of developing malignant diseases such as breast cancer, endometrial tumor or prostate carcinoma, but the molecular basis for this is not well understood. Potential mechanisms include increased bioavailability of adipocytokines (__e.g.__ leptin
While TRAIL is relatively non-toxic to normal cells, it can selectively induce apoptosis in many types of transformed cells. Nevertheless, some non-small cell lung cancer (NSCLC) cells are particularly resistant to the effects of TRAIL. Here, we report that in combination with naringenin exposure to
## Abstract Raloxifene (RAL), a selective estrogen receptor (ER) modulator (SERM) seems to induce apoptosis in both androgen‐dependent and ‐independent prostate cell (PC) lines via activation of ERβ and an antagonistic effect on ERα. In this study, we evaluated the effects of RAL on epithelial PC g